(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -38.31%183.68M | -50.00%68.4M | -14.75%543.94M | -15.60%402.6M | 6.98%297.75M | -12.81%136.8M | -11.96%638.02M | -17.53%477M | -27.61%278.34M | 0.51%156.9M |
Operating income | -38.31%183.68M | -14.75%543.94M | 6.98%297.75M | -11.96%638.02M | -27.61%278.34M | |||||
Cost of sales | 40.65%-145.4M | ---- | 34.84%-423.61M | ---- | 8.34%-245M | ---- | 7.55%-650.11M | ---- | 17.04%-267.31M | ---- |
Operating expenses | 40.65%-145.4M | 34.84%-423.61M | 8.34%-245M | 7.55%-650.11M | 17.04%-267.31M | |||||
Gross profit | -27.43%38.28M | 1,095.28%120.33M | 378.13%52.75M | -156.23%-12.09M | -82.28%11.03M | |||||
Selling expenses | 14.36%-9.37M | ---- | 29.82%-24.37M | ---- | 42.23%-10.94M | ---- | 9.82%-34.72M | ---- | -43.37%-18.94M | ---- |
Administrative expenses | 0.87%-33.8M | ---- | 53.04%-81.62M | ---- | 47.48%-34.09M | ---- | -31.59%-173.81M | ---- | -34.81%-64.92M | ---- |
Research and development expenses | 6.21%-59.94M | ---- | 44.18%-136.93M | ---- | 48.06%-63.91M | ---- | -37.27%-245.28M | ---- | -59.47%-123.04M | ---- |
Impairment and provision | 293.45%1.3M | ---- | 50.11%-17.61M | ---- | 99.25%-672K | ---- | -210.90%-35.29M | ---- | -2,143.63%-89.75M | ---- |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---76.92M | ---- |
-Other impairment is provision | 293.45%1.3M | ---- | 50.11%-17.61M | ---- | 94.76%-672K | ---- | -210.90%-35.29M | ---- | -220.55%-12.82M | ---- |
Special items of operating profit | -422.14%-26.28M | ---- | 30,414.61%566.05M | ---- | 138.10%8.16M | ---- | -95.55%1.86M | ---- | -343.81%-21.41M | ---- |
Operating profit | -84.38%-89.81M | 185.28%425.86M | 84.13%-48.71M | -96.37%-499.34M | -329.63%-307.03M | |||||
Financing cost | 45.53%-1.05M | ---- | -1.16%-4.97M | ---- | 5.98%-1.93M | ---- | -52.72%-4.92M | ---- | 8.95%-2.06M | ---- |
Share of profits of associates | 104.79%56K | ---- | -179.76%-3.94M | ---- | -167.17%-1.17M | ---- | -67.12%4.94M | ---- | -82.96%1.74M | ---- |
Earning before tax | -75.26%-90.81M | 183.50%416.94M | 83.14%-51.81M | -105.92%-499.32M | -383.89%-307.34M | |||||
Tax | -47.73%770K | ---- | -884.71%-83.77M | ---- | 108.37%1.47M | ---- | -225.32%-8.51M | ---- | -558.19%-17.6M | ---- |
After-tax profit from continuing operations | -78.86%-90.04M | 165.61%333.17M | 84.51%-50.34M | -115.46%-507.82M | -444.53%-324.94M | |||||
Earning after tax | -78.86%-90.04M | 165.61%333.17M | 84.51%-50.34M | -106.83%-507.82M | -367.51%-324.94M | |||||
Minority profit | -11,542.65%-7.78M | ---- | -781.24%-11.11M | ---- | 175.56%68K | ---- | 486.69%1.63M | ---- | -143.90%-90K | ---- |
Profit attributable to shareholders | -63.19%-82.26M | 167.58%344.29M | 84.48%-50.41M | -107.26%-509.45M | -366.00%-324.85M | |||||
Basic earnings per share | -65.22%-0.038 | 169.15%0.1607 | 84.35%-0.023 | -119.25%-0.2324 | -390.00%-0.147 | |||||
Diluted earnings per share | -65.22%-0.038 | 169.15%0.1607 | 84.35%-0.023 | -119.25%-0.2324 | -390.00%-0.147 | |||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data